Estimates Revisions Ovid Therapeutics Inc.
Stocks
OVID
US6904691010
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.800 USD | +2.19% |
|
-1.06% | +71.78% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Stocks
- OVID Stock
- Consensus Ovid Therapeutics Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
